MPS Powered by Eureka

Current Drug Metabolism

ISSN: 1389-2002 (Print)
eISSN: 1875-5453 (Online)

Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. The journal serves as an international forum for the publication of full-length/mini review articles and guest edited issues in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the most important developments. The journal covers the following general topic areas: pharmaceutics, pharmacokinetics, toxicology, and most importantly drug metabolism.

More specifically, in vitro and in vivo drug metabolism of phase I and phase II enzymes or metabolic pathways; drug-drug interactions and enzyme kinetics; pharmacokinetics, pharmacokinetic-pharmacodynamic modeling, and toxicokinetics; interspecies differences in metabolism or pharmacokinetics, species scaling and extrapolations; drug transporters; target organ toxicity and interindividual variability in drug exposure-response; extrahepatic metabolism; bioactivation, reactive metabolites, and developments for the identification of drug metabolites. Preclinical and clinical reviews describing the drug metabolism and pharmacokinetics of marketed drugs or drug classes.
Journal Impact Factor : 2.1

Special Issues With Active Call for Papers

Submission closes on: Apr 30, 2025
Therapeutic drug monitoring in clinical applications

Therapeutic Drug Monitoring (TDM) is a special issue focusing on the monitoring of drug concentrations in clinical therapy, aiming to optimize drug therapy, reduce drug interactions and ensure patient safety through quantitative analysis of drug concentrations in patient's; body fluids. TDM is of great significance in the current medical field, especially in the fields of individualized therapy, assessment of drug-drug interactions, determination of drug compliance, and prevention of drug toxicity, etc. It has a key... see more

Submission closes on: Mar 31, 2025
Safety evaluation of vaccine combination

Vaccine combination safety evaluation is a critical field within immunology and public health that focuses on assessing the safety and efficacy of combining different vaccines to maximize protection against various diseases while minimizing potential adverse effects. This process is significant because it ensures that vaccines can be administered together without compromising the immune response or causing harm to the individual receiving them. The current relevance of this field is heightened due to the ongoing development... see more

Submission closes on: Dec 08, 2024
Metabolism-Mediated Xenobiotic Toxicity

Considering the potent modulation of biotransformation enzyme expression and activities by various therapeutic drugs and environmental chemicals, and the commonly combined exposure of humans to both drugs and the ever increasing environmental pollutants simultaneously, knowledge about the combined toxic effects by modulating biotransformation enzymes, such as P450s, UDP- glucuronosyltransferases, and sulfotransferases in regard to changes, either activation or detoxification, in the toxicity of the coexposing compounds, is critically important in creating strategies and measures for... see more